Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Dementia Discovery Fund

This page shows the latest Dementia Discovery Fund news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: DDF hits £250m investment, Hard Brexit could cost UK £100bn in trade and troublesome results for Pfizer’s Ibrance

Daily Brief: DDF hits £250m investment, Hard Brexit could cost UK £100bn in trade and troublesome results for Pfizer’s Ibrance

The Dementia Discovery Fund (DDF) confirmed yesterday that it had raised £250m ($350m), boosted by a $60m investment from US non-profit organisation AARP aimed at helping older people live healthier ... lives. The fundraising far exceeded its initial

Latest news

  • British Business Bank sets up £2.5bn fund for ‘unicorn’ firms British Business Bank sets up £2.5bn fund for ‘unicorn’ firms

    A new UK government-backed investment vehicle to provide long-term capital for British businesses has been launched, with a fund backing dementia drug developers among the first to benefit. ... The Dementia Discovery Fund is one of two VCs given funding

  • Pfizer drops neuroscience R&D, cutting 300 jobs Pfizer drops neuroscience R&D, cutting 300 jobs

    It will also set up a dedicated venture capital fund to invest in other companies carrying out neuroscience R&D and “support continued efforts to advance the field”. ... Pfizer is already one of the founder members of the cross-company Dementia

  • Woodford investment pushes Dementia Discovery Fund to £100m Woodford investment pushes Dementia Discovery Fund to £100m

    Woodford investment pushes Dementia Discovery Fund to £100m. Fund aims to back 40 projects over its 15-year term. ... Thanks to a £15m pledge from Neil Woodford's investment group, the public-private Dementia Discovery Fund (DDF) has now raised close

  • GSK and J&J back new UK dementia discovery fund GSK and J&J back new UK dementia discovery fund

    GSK and J&J back new UK dementia discovery fund. Pharma giants collaborate with government to find new treatments. ... GlaxoSmithKline, Johnson &Johnson and Pfizer have signed up to support a new UK government dementia discovery fund.

  • Freeman: More pharma-charity research partnerships needed Freeman: More pharma-charity research partnerships needed

    Similar partnerships have been launched in recent years for conditions, including dementia and Parkinson's disease - both areas of significant unmet medical need. ... Earlier this year, Lilly, Pfizer, GlaxoSmithKline, Biogen Idec and Johnson &Johnson

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2)

    and GlaxoSmithKline have each signed significant strategic discovery deals during Eva-Lotta’s five years at Immunocore. ... the UK’s new Dementia Discovery Fund (DDF) and serves on the DDF Investment Committee.

  • The world is our laboratory The world is our laboratory

    This year, through J&J Innovation, we will invest $10m into the UK government-led Global Dementia Discovery Fund, supporting innovative research into the area. ... This was set up in 2013 to identify innovative solutions for dementia care.

  • Pharma deals in March 2015 Pharma deals in March 2015

    This month saw GSK invest $25m, J&J $10m and the UK Government $22m into the Dementia Discovery fund, a joint initiative also including Lilly, Biogen and Pfizer to research treatments

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Forecasting in Forgotten Markets

    To help address a lack of investment in novel dementia science a new £100M Dementia Discovery Fund ( ) was launched towards the end of last year. ... Managed by SV Life Sciences the fund is focused primarily on Phase I and II research and aims to help

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...

Quick links

Infographics

Multimedia